Sakaida I - Search Results

1

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.

Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I. Terai S, et al. Among authors: sakaida i. Stem Cells. 2006 Oct;24(10):2292-8. doi: 10.1634/stemcells.2005-0542. Epub 2006 Jun 15. Stem Cells. 2006. PMID: 16778155 Clinical Trial.

2

Detection of proliferating hepatocytes by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) in patients with acute hepatic failure.

Kayano K, Yasunaga M, Kubota M, Takenaka K, Mori K, Yamashita A, Kubo Y, Sakaida I, Okita K, Sanuki K. Kayano K, et al. Among authors: sakaida i. Liver. 1992 Jun;12(3):132-6. doi: 10.1111/j.1600-0676.1992.tb00571.x. Liver. 1992. PMID: 1380112

3

Protective effect of deferoxamine for acetaminophen induced liver injury.

Sakaida I, Kayano K, Kubota M, Mori K, Takenaka K, Yasunaga M, Okita K. Sakaida I, et al. Gastroenterol Jpn. 1992 Jun;27(3):426. doi: 10.1007/BF02777767. Gastroenterol Jpn. 1992. PMID: 1624086 No abstract available.

4

Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine.

Sakaida I, Kayano K, Wasaki S, Nagatomi A, Matsumura Y, Okita K. Sakaida I, et al. Scand J Gastroenterol. 1995 Jan;30(1):61-7. doi: 10.3109/00365529509093237. Scand J Gastroenterol. 1995. PMID: 7701253

5

The effect of E3330 on active oxygen generation by isolated hepatic macrophages in rats.

Wasaki S, Sakaida I, Nagatomi A, Matsumura Y, Yasunaga M, Okita K. Wasaki S, et al. Among authors: sakaida i. J Gastroenterol. 1995 Apr;30(2):273-4. doi: 10.1007/BF02348678. J Gastroenterol. 1995. PMID: 7773361 No abstract available.

6

Prevention of fibrosis reduces enzyme-altered lesions in the rat liver.

Sakaida I, Kubota M, Kayano K, Takenaka K, Mori K, Okita K. Sakaida I, et al. Carcinogenesis. 1994 Oct;15(10):2201-6. doi: 10.1093/carcin/15.10.2201. Carcinogenesis. 1994. PMID: 7955054

7

Functional differences between activated and normal rat liver macrophages: LPS uptake capacity by flow cytometric analysis in contrast with TNF-alpha release.

Kayano K, Sakaida I, Kubota M, Yasunaga M, Okita K. Kayano K, et al. Among authors: sakaida i. Liver. 1995 Oct;15(5):253-9. doi: 10.1111/j.1600-0676.1995.tb00681.x. Liver. 1995. PMID: 8531595

8

New prolyl 4-hydroxylase inhibitor reduces procollagen gene expression and enzyme-altered lesions in rat liver cirrhosis.

Sakaida I, Okita K. Sakaida I, et al. J Gastroenterol Hepatol. 1995;10 Suppl 1:S63-4. doi: 10.1111/j.1440-1746.1995.tb01801.x. J Gastroenterol Hepatol. 1995. PMID: 8589346

9

The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet.

Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K. Sakaida I, et al. Hepatology. 1996 Apr;23(4):755-63. doi: 10.1053/jhep.1996.v23.pm0008666329. Hepatology. 1996. PMID: 8666329

10

Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.

Masuhara M, Yasunaga M, Tanigawa K, Tamura F, Yamashita S, Sakaida I, Okita K. Masuhara M, et al. Among authors: sakaida i. Hepatology. 1996 Aug;24(2):323-9. doi: 10.1053/jhep.1996.v24.pm0008690400. Hepatology. 1996. PMID: 8690400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters